| 1 |
Fan C, Xue H, Xu J, Wang S, Wu M, Chen L, Xu L. Host-Specific Differences in Gut Microbiota Between Cricetulus barabensis and Phodopus sungorus. Curr Microbiol 2023;80:149. [PMID: 36971869 DOI: 10.1007/s00284-023-03274-4] [Reference Citation Analysis]
|
| 2 |
Wang Z, Wang Y, Gao P, Ding J. Immune checkpoint inhibitor resistance in hepatocellular carcinoma. Cancer Lett 2023;555:216038. [PMID: 36529238 DOI: 10.1016/j.canlet.2022.216038] [Reference Citation Analysis]
|
| 3 |
Wu D, Zhang C, Liu Y, Yao J, Yang X, Wu S, Du J, Yang X. Beyond faecal microbiota transplantation, the non-negligible role of faecal virome or bacteriophage transplantation. J Microbiol Immunol Infect 2023:S1684-1182(23)00042-7. [PMID: 36890066 DOI: 10.1016/j.jmii.2023.02.005] [Reference Citation Analysis]
|
| 4 |
Domingues C, Cabral C, Jarak I, Veiga F, Dourado M, Figueiras A. The Debate between the Human Microbiota and Immune System in Treating Aerodigestive and Digestive Tract Cancers: A Review. Vaccines 2023;11:492. [DOI: 10.3390/vaccines11030492] [Reference Citation Analysis]
|
| 5 |
Vitiello A, Ferrara F, Zovi A. The direct correlation between microbiota and SARS-CoV-2 infectious disease. Inflammopharmacology 2023;:1-8. [PMID: 36725821 DOI: 10.1007/s10787-023-01145-9] [Reference Citation Analysis]
|
| 6 |
Dora D, Bokhari SMZ, Aloss K, Takacs P, Desnoix JZ, Szklenárik G, Hurley PD, Lohinai Z. Implication of the Gut Microbiome and Microbial-Derived Metabolites in Immune-Related Adverse Events: Emergence of Novel Biomarkers for Cancer Immunotherapy. Int J Mol Sci 2023;24. [PMID: 36769093 DOI: 10.3390/ijms24032769] [Reference Citation Analysis]
|
| 7 |
Yuan H, Gui R, Wang Z, Fang F, Zhao H. Gut microbiota: A novel and potential target for radioimmunotherapy in colorectal cancer. Front Immunol 2023;14:1128774. [PMID: 36798129 DOI: 10.3389/fimmu.2023.1128774] [Reference Citation Analysis]
|
| 8 |
Knisely A, Seo YD, Wargo JA, Chelvanambi M. Monitoring and Modulating Diet and Gut Microbes to Enhance Response and Reduce Toxicity to Cancer Treatment. Cancers (Basel) 2023;15. [PMID: 36765735 DOI: 10.3390/cancers15030777] [Reference Citation Analysis]
|
| 9 |
Li N, Wang Y, Wei P, Min Y, Yu M, Zhou G, Yuan G, Sun J, Dai H, Zhou E, He W, Sheng M, Gao K, Zheng M, Sun W, Zhou D, Zhang L. Causal Effects of Specific Gut Microbiota on Chronic Kidney Diseases and Renal Function-A Two-Sample Mendelian Randomization Study. Nutrients 2023;15. [PMID: 36678231 DOI: 10.3390/nu15020360] [Reference Citation Analysis]
|
| 10 |
Spiliopoulou P, Vornicova O, Genta S, Spreafico A. Shaping the Future of Immunotherapy Targets and Biomarkers in Melanoma and Non-Melanoma Cutaneous Cancers. Int J Mol Sci 2023;24. [PMID: 36674809 DOI: 10.3390/ijms24021294] [Reference Citation Analysis]
|
| 11 |
Wang L, Tang L, Zhai D, Song M, Li W, Xu S, Jiang S, Meng H, Liang J, Wang Y, Zhang B. The role of the sex hormone-gut microbiome axis in tumor immunotherapy. Gut Microbes 2023;15:2185035. [PMID: 36880651 DOI: 10.1080/19490976.2023.2185035] [Reference Citation Analysis]
|
| 12 |
Gebert JT, Scribano F, Engevik KA, Perry JL, Hyser JM. Gastrointestinal organoids in the study of viral infections. Am J Physiol Gastrointest Liver Physiol 2023;324:G51-9. [PMID: 36414538 DOI: 10.1152/ajpgi.00152.2022] [Reference Citation Analysis]
|
| 13 |
Li Z, Ke X, Zuo D, Wang Z, Fang F, Li B. New Insights into the Relationship between Gut Microbiota and Radiotherapy for Cancer. Nutrients 2022;15. [PMID: 36615706 DOI: 10.3390/nu15010048] [Reference Citation Analysis]
|
| 14 |
Wan Z, Zheng J, Zhu Z, Sang L, Zhu J, Luo S, Zhao Y, Wang R, Zhang Y, Hao K, Chen L, Du J, Kan J, He H. Intermediate role of gut microbiota in vitamin B nutrition and its influences on human health. Front Nutr 2022;9:1031502. [PMID: 36583209 DOI: 10.3389/fnut.2022.1031502] [Reference Citation Analysis]
|
| 15 |
Dai XC, Zhang YH, Huang YL, Wu XT, Fang YJ, Gao YJ, Wang F. Calorie restriction remodels gut microbiota and suppresses tumorigenesis of colorectal cancer in mice. Exp Ther Med 2023;25:59. [PMID: 36588818 DOI: 10.3892/etm.2022.11758] [Reference Citation Analysis]
|
| 16 |
Pîrlog CF, Paroșanu AI, Slavu CO, Olaru M, Popa AM, Iaciu C, Niță I, Moțatu P, Horia C, Manolescu LSC, Nițipir C. Nivolumab Hypersensitivity Reactions a Myth or Reality in Solid Tumors-A Systematic Review of the Literature. Curr Oncol 2022;29:9428-36. [PMID: 36547155 DOI: 10.3390/curroncol29120741] [Reference Citation Analysis]
|
| 17 |
Eguchi H, Ozkan J, Holland MJ. Editorial: Next-generation sequencing in ophthalmology: The microbiome in ocular health and disease. Front Cell Infect Microbiol 2022;12:1080932. [PMID: 36699725 DOI: 10.3389/fcimb.2022.1080932] [Reference Citation Analysis]
|
| 18 |
Leitao Sun, Zhenzheng Zhu, Xinru Jia, Xiangchang Ying, Binbin Wang, Peipei Wang, Shuo Zhang, Jieru Yu. The difference of human gut microbiome in colorectal cancer with and without metastases. Front Oncol 2022;12:982744. [PMID: 36387258 DOI: 10.3389/fonc.2022.982744] [Reference Citation Analysis]
|
| 19 |
Guardamagna M, Berciano-Guerrero MA, Villaescusa-González B, Perez-Ruiz E, Oliver J, Lavado-Valenzuela R, Rueda-Dominguez A, Barragán I, Queipo-Ortuño MI. Gut Microbiota and Therapy in Metastatic Melanoma: Focus on MAPK Pathway Inhibition. Int J Mol Sci 2022;23:11990. [PMID: 36233289 DOI: 10.3390/ijms231911990] [Reference Citation Analysis]
|
| 20 |
Deluce J, Maleki Vareki S, Fernandes R. The role of gut microbiome in immune modulation in metastatic renal cell carcinoma. Ther Adv Med Oncol 2022;14:17588359221122714. [PMID: 36105887 DOI: 10.1177/17588359221122714] [Reference Citation Analysis]
|
| 21 |
Li Y, Huang X, Tong D, Jiang C, Zhu X, Wei Z, Gong T, Jin C. Relationships among microbiota, gastric cancer, and immunotherapy. Front Microbiol 2022;13:987763. [DOI: 10.3389/fmicb.2022.987763] [Reference Citation Analysis]
|
| 22 |
Yang S, Zhao S, Ye Y, Jia L, Lou Y. Global research trends on the links between gut microbiota and cancer immunotherapy: A bibliometric analysis (2012-2021). Front Immunol 2022;13:952546. [DOI: 10.3389/fimmu.2022.952546] [Reference Citation Analysis]
|
| 23 |
Cardenas LM, Deluce JE, Khan S, Gulam O, Maleki Vareki S, Fernandes R, Lalani AA. Next Wave of Targets in the Treatment of Advanced Renal Cell Carcinoma. Current Oncology 2022;29:5426-5441. [DOI: 10.3390/curroncol29080429] [Reference Citation Analysis]
|
| 24 |
Zhu L, Huang Y, Li H, Shao S. Helicobacter pylori promotes gastric cancer progression through the tumor microenvironment. Appl Microbiol Biotechnol 2022. [PMID: 35723694 DOI: 10.1007/s00253-022-12011-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
